KPTI: Abate Kristin sold $2K of stock
By AlphaYouPublished Form 4
Abate Kristin
Reporting filer
Abate Kristin reported selling 4,788 shares of Karyopharm Therapeutics Inc. for about $2K ($0.34 a share on average). Form 4 filed Oct 19, 2026 lists 1 entry.
See the price move since this trade →
- Disclosed
- Oct 19, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Abate Kristin | 2026-10-16 | S | Sale | 4788 | 0.344 | 18,616 | 3 days | Filed terms
|
Common Stock
- Owner
- Abate Kristin
- Date
- 2026-10-16
- Code
- S
- Action
- Sale
- Quantity
- 4788
- Price
- 0.344
- Following holdings
- 18,616
- Reporting delay
- 3 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-10-16
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: false
- id: F1
- transaction Shares: 4788
- transaction Price Per Share: 0.344
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 18616
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Abate Kristin: Chief Accounting Officer.
- F1: This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on May 27, 2021, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units. The sale does not represent a discretionary trade by the reporting person.
Original sources
Prepared automatically from public filing data. Report a correction.